Nitric oxide and hemodynamic impairment

Digestion

Volumn 59, Issue SUPPL. 2, 1998, Pages 6-7

  Groszmann, Roberto J ^a,b,c  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Liver microcirculation; Nitric oxide; Portal hypertension; Splanchnic circulation

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN;

BLOOD VESSEL TONE; CHRONIC LIVER DISEASE; CONFERENCE PAPER; HEMODYNAMICS; HUMAN; LIVER; MICROCIRCULATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; VASCULAR ENDOTHELIUM; VASODILATATION;

HUMANS; HYPERTENSION, PORTAL; LIVER CIRCULATION; NITRIC OXIDE;

EID: 0031856917     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051411     Document Type: Conference Paper

References (10)

1. Casadevall M, Panes J, Pique JM, Marroni J, Bosch J, Whittle BJ: Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology 1993;18:628-634.
2. ω-nitro-L-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993;17:84-90.
3. Garcia-Pagan JC, Fernandez M, Bernadich C, Pizcueta P, Pique JM, Bosch J, Rodes J: Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. Am J Physiol 1994;267:G984-G990.
4. Karatapanis S, McCormick PA, Kakad S, Chin JK, Islam M, Jeremy J, Harry D, McIntyre N, Burroughs AK, Jacobs M: Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats. Hepatology 1994;20: 1516-1521.
5. Vallance P, Moncada S: Hyperdynamic circulation in cirrhosis: A role lor nitric oxide? Lancet 1991;337:776-778.
6. Lopez-Talavera JC, Merrill WW, Groszmann RJ: Tumor necrosis factor-α: A major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenteroloay 1995;108:761-767.
7. Lopez-Talavera JC, Cadelina GW, Olchowski J, Merrill WW, Groszmann RJ: Thalidomide inhibits tumor necrosis factor-α, decreases nitric oxide synthesis and ameliorates the hyperdynamic circulatory syndrome in portal hypertensive rats. Hepatology 1996;23:1616-1621.
8. Mittal MK, Gupta TK, Lee FY, Sieber CC, Groszmann RJ: Nitric oxide modulates vascular tone in normal rat liver. Am J Physiol 1994;267: G416-G422.
9. Gupta TK, Groszmann RJ: Administration of L-arginine, the physiological precursor of nitric oxide, reduces portal perfusion pressure and ameliorates hepatic vascular hyperreactivity in experimental cirrhosis. Hepatology 1994;20: 200A.
10. Gupta TK, Chung M, Sessa WC, Groszmann RJ: Impaired endothelial function in the intrahepatic circulation in cirrhosis. Hepatology 1995;22:156A.